{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:30:05Z","timestamp":1787905805885,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jcf.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T08:21:35Z","timestamp":1534580495000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Rebecca","family":"Dezube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Rykiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Diener-West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott C.","family":"Dasenbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2018.07.005_bb0005","series-title":"2016 Annual Data Report","author":"Cystic Fibrosis Foundation Patient Registry","year":"2017"},{"key":"10.1016\/j.jcf.2018.07.005_bb0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2018.07.005_bb0015","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent methicillin-resistant staphylococcus aureus and rate of fev1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2018.07.005_bb0020","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2018.07.005_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thoraxjnl-2016-208949","article-title":"Microbiological efficacy of early mrsa treatment in cystic fibrosis in a randomised controlled trial","volume":"72","author":"Muhlebach","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2018.07.005_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcf.2009.11.009","article-title":"Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant staphylococcus aureus at large cystic fibrosis centres","volume":"9","author":"Doe","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.07.005_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhin.2006.10.011","article-title":"Successful decolonization of methicillin-resistant staphylococcus aureus in paediatric patients with cystic fibrosis (cf) using a three-step protocol","volume":"65","author":"Macfarlane","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jcf.2018.07.005_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhin.2003.12.003","article-title":"Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant staphylococcus aureus (mrsa) isolation in adults with cystic fibrosis and chronic mrsa infection","volume":"56","author":"Garske","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jcf.2018.07.005_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.10231","article-title":"Methicillin-resistant staphylococcus aureus in children with cystic fibrosis: an eradication protocol","volume":"36","author":"Solis","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.07.005_bb0050","article-title":"Interventions for the eradication of meticillin-resistant staphylococcus aureus (mrsa) in people with cystic fibrosis","volume":"2","author":"Lo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2018.07.005_bb0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2018.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1513\/AnnalsATS.201402-050AS","article-title":"Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant staphylococcus aureus, gram-negative bacteria, and multiple infections","volume":"11","author":"Chmiel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2018.07.005_bb0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/001857870403900705","article-title":"Vancomycin: Aerosolization","volume":"39","author":"Generali","year":"2004","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.jcf.2018.07.005_bb0070","first-page":"1233","article-title":"Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus","volume":"33","author":"Shirai","year":"1995","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.jcf.2018.07.005_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ppul.22682","article-title":"Poster session abstracts: safety and pharmacokinetics of inhaled vancomycin in individuals with cystic fibrosis","volume":"47","author":"Jennings","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2018.07.005_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1378\/chest.127.2.522","article-title":"Bronchial constriction and inhaled colistin in cystic fibrosis","volume":"127","author":"Alothman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.07.005_bb0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ijantimicag.2011.01.018","article-title":"Increased rifampicin resistance in blood isolates of meticillin-resistant staphylococcus aureus (mrsa) amongst patients exposed to rifampicin-containing antituberculous treatment","volume":"37","author":"Tan","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcf.2018.07.005_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2180-12-46","article-title":"Genetic basis of rifampicin resistance in methicillin-resistant staphylococcus aureus suggests clonal expansion in hospitals in cape town, South Africa","volume":"12","author":"Jansen Van Rensburg","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcf.2018.07.005_bb0095","article-title":"Prophylactic anti-staphylococcal antibiotics for cystic fibrosis","volume":"4","author":"Smyth","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jcf.2018.07.005_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.diagmicrobio.2017.11.012","article-title":"Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant staphylococcus aureus in cystic fibrosis patients","volume":"90","author":"Suwantarat","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jcf.2018.07.005_bb0105","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/AAC.00742-15","article-title":"Thymidine-dependent staphylococcus aureus small-colony variants are induced by trimethoprim-sulfamethoxazole (sxt) and have increased fitness during sxt challenge","volume":"59","author":"Kriegeskorte","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2018.07.005_bb0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jcf.2017.04.010","article-title":"Risk factors for persistent methicillin-resistant staphylococcus aureus infection in cystic fibrosis","volume":"16","author":"Jennings","year":"2017","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318307021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318307021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:35Z","timestamp":1761601295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318307021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1569199318307021"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.07.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}